[Federal Register Volume 60, Number 122 (Monday, June 26, 1995)]
[Notices]
[Page 32964]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-15475]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has made final findings of scientific misconduct in the following 
case:
    Farooq A. Siddiqui, Ph.D., Roswell Park Cancer Institute: The 
Division of Research Investigations (DRI) of the Office of Research 
Integrity (ORI) completed an investigation into possible scientific 
misconduct on the part of Dr. Siddiqui while he was an employee of 
Roswell Park Memorial Institute. ORI finds that Dr. Siddiqui committed 
scientific misconduct by misrepresenting data in a published article. 
The research was supported by a grant award from the National Cancer 
Institute, National Institutes of Health, Public Health Service (PHS).
    Dr. Siddiqui agreed not to appeal the misconduct finding as part of 
a Voluntary Settlement Agreement under which, for a period of two 
years, he will not apply as a principal or coprincipal investigator in 
any nonprocurement transactions (grants and cooperative agreements) or 
as a principal or coprincipal in any contract or subcontract with the 
United States Government. Dr. Siddiqui also is prohibited from serving 
on any Public Health Service advisory committee, board, and/or peer 
review committee for a period of two years. Also, for a two-year period 
the institution where he is employed will supervise his performance of 
work on any covered transaction including a periodic review of primary 
data, and certify the accuracy of any such data used in any United 
States Government Public Health Service grant application, contract 
proposal, or which is otherwise publicly reported. He has agreed to 
submit a letter to the journal Biochemica et Biophysica Acta (BBA) to 
retract the article entitled ``Purification and Immunological 
Characterization of DNA Polymerase-alpha from Human Acute Lymphoblastic 
Leukemia Cells'' (BBA, 745:154-161, 1983).

FOR FURTHER INFORMATION, CONTACT: Director, Division of Research 
Investigations, Office of Research Integrity, 301-443-5330.
Lyle W. Bivens,
Director, Office of Research Integrity.
[FR Doc. 95-15475 Filed 6-23-95; 8:45 am]
BILLING CODE 4160-17-P